Member Info for Aldebaran

Don't embarrass yourself Big Show.

Yes loss making companies can increase their NAV. (Net Asset Value). Please do a bit of research before posting stuff like that because it highlights how amateur you are.

1 example is placings. Once funds raised the NAV increases but that doesn't suddenly make a company profitable does it.

You see there is a lot of things you dont understand and the jiggery pokery going in at audiboom with them shouting about adjusted EBITDA is a real concern for me. 60m valuation is high for a loss making company that I doubt will even then 10% of its sales into cash this year.

Theyre not generating cash though.

All they bang on about is revenue, viewers, gross profit, adjusted EBITDA etc...

Where is the net profit. How much free cash flow are they generating? Zero. Infact less than zero.

Ok they have some fancy predictions for this year, 70m dollar booked revenue but how much are they converting to cash, at least 7m dollar i hope as that's a 10% conversion (note Warren buffet aims for 15 - 20% conversion) so even 10% conversion doesn't make audioboom a screaming buy. The valuation here seems lofty based on the numbers to me. It prob seems cheap because of where it was but that was all fueled by hype and unsubstantiated talks of a buyout

So 2 weeks mrindia amd when that deadline comes and goes what then? I just find it highly suspicious that leading up to this major inflexion point where big pharma are going to come rushing in, the price is falling...

Don't you find that a little odd, really?

On the contrary, Avacta has now bottomed with highest volume and highest price in past year. New commercial directors appointed and company have stated they are in multiple partnering discussions for there platform technology i.e. they are now at the commercialisation phase. Price has responded accordingly and bust upwards through the 200dma and even short is now closing.

As for you expecting it to be bust in 2years, you seriously best hope not because they have the most exquisite tumour targeting technology ever invented. It can deposit 100x more drug into the tumour than the blood. This isn't made up, this is scientific data just been presented at major oncology conferences in Europe and USA, no doubt this latest data has also been why SP is responding.

If its so good why is price down so much you ask?

Well same reason as AFC now. It has been a cash hungry company needing to rely on placings at ever lower prices to progress clinical trials and shorts have piled on. Now shorts closing and significant new money coming in (confirmed by volume), it has hit the inflexion point.

The kind of inflexion point which AFC will hopefully hit in 2027/2028. Right now, you're too early here guys. Way to early and if and when you sell and look from the outside you realise your bias

Manipulation, market maker games, people want your shares cheap. Yeah ok m8.

The reality is, AFC are nowhere near being profitable and have faced nothing but setbacks and delays and had Mr Bond over promising and under delivering.

Now, that doesn't mean AFC won't or cant come good or that new management cant turn it around because that is definitely possible.

It's been a terrible market these past few years with cash hungry small caps suffering particularly badly. AFC have new caught up in that also.

The point I'm making here is that there's still a lot more downside to come here as you're looking at end of 2027 before crucial milestones are hit and that's without any delay. A lot can change in that time.

What I dont like to see is the share price here fall below the 200dma in increasing volume and now below last placing price so where is support?

This might come good long term but investors here are in for more prolonged pain first I think. Which is a shame because there are some clever thoughtful people here who would and can do well in other stocks

Just had a check here and price falling with increasing volume and crossed below the 200dma.

I expect ATL to be tested at some point soon here as investors realise there are better opportunities in the near term.

In isolation its difficult to say whether the silence is good or bad. Generally id say bad but maybe that doesn't apply here.

What IS telling is when you marry up the silence with a falling share price giving more of a likelihood than not things not gone or going well. As ever us PI's will be the last to no. Just dont ignore price folks. Even if pingu is saying buys outweigh sells and market makers are playing games and alde wants your shares cheap etc etc seen it on every bulletin bored. It's all nonsense. Share price is all about supply and demand. Simples

"Traders only make money on things going down nowadays"

Really?

REALLY ??

Think you'll find plenty of stocks and indices are in uptrends, just not HEMO. Take Avacta for example, price more than doubled from its low point with significant volume and bust through the 200dma. Even the short has started to close such that they dont envisage much more downside if any. This is just one example of many so I dont agree with your comment about traders only making money when stocks go down.

Hydrogen boom to inflate market: Allianz - Insurance News - insuranceNEWS.com.au https://www.insurancenews.com.au/international/hydrogen-boom-to-inflate-market-allianz

Seems promising but always in the future.

Actually 90% dont make it but of the 10% that do, they go on to multiply by many orders of magnitude.

Avacta doesn't have a new drug by the way, it is a new drug delivery system that only activates existing warheads when they reach the tumour thereby sparing healthy tissues and all those nasty side effects such as hair loss and heart toxicity etc...

Trial results so far showing 90% disease control rate in humans with no side effects. So I suspect avacta is in the 10% of company's that do make it. Why do you say its high risk have you even seen the data and seen that shorts are now closing?

1 in 3 of us will be effected by cancer , its worth taking note of avacta especially since the start of a new uptrend has begun.

Other shares like avacta are just starting to move now, breaking through 200dma with volume after a prolonged downtrend. Worth looking at while waiting for AFC. My belief is that nothing game-changing will happen here for another couple of years and price likely to continue falling in that time.

Keep an eye on AFC and try to buy in or add when they're on the cusp of profitability if they're a good price i.e. dont pay too much also. Smart money doesn't.

Some.people become fixated on making money and being right from one company when actually being right is irrelevant. Just make money folks, its out there now to be had and tomorrow is never guaranteed. As I say, other stocks are in uptrends or just starting their uptrends. AFC are a couple years away from this point and that's IF they get there which they might not

Paying the CLN via a private placing has also arguably been one of, if not THE driving force behind GSA reducing there short position.

Avacta now have more options financially and are at least on the radar if many HNWI.

Small commercial deal for a third party warhead before Christmas gives us the validation we need plus extends the cash runway nicely. Should easily be enough to see us get enough data on TNBC for a partnership deal and then with 6103 in clinical trials we're off to the stratosphere no looking back. This next 12 months will define the company's trajectory. Feels like this is finally the start of that hockey stick move we've all been waiting for

Pingu if the share price is moving on low volume then it shows there is zero support or resistance at that level. This isn't manipulation or market maker games etc etc all the usual lies PI's tell themselves to comfort themselves.

Sadly, price falling on small sells means no support and with the silence deafening here regarding trial update then I dont see that as a good thing. Exact opposite is happening at Avacta right now so its interesting to see how things work in opposite directions

Death by a thousand tiny cuts here.

What we should all be asking is why the share price is approaching all time lows if everything going so great. My belief is that its not hence the continual decline

Looks like lloyds is in for a nice run, reverse head and shoulders pattern followed by a lovely bowl breakout. Well done to all here. I sold a bit ago and now regretting it. Taken another small position

Play the ball not the man. What is wrong with the figures?

If you can give me a logical answer why Avacta doesn't have the potential to at least 100 bag id be amazed.

Tell me what is wrong with these figures.. when you're considering upside possibility

https://x.com/RAH00084/status/1951904097482793418?t=2yfPGswP8fv9DWUc2BzO3A&s=19

Lol just seen

For me that says more about you than me. The fact you are so insecure and overexposed with audioboom that you feel the need to go to another bulletin bored to start a thread about me but each to there own I won't change and I won't stop posting. I would prefer to stick to audioboom on this bored and avacta on the avacta bored etc rather than mixing them up and talking about each other etc but each to there own.

As for avacta hitting 100x from here that is only 20bn, given there technology can revolutionise a 180bn market easily then its not exactly a stretch to get to those valuations 20 - 50bn especially given precedents. Don't believe me? Use the avacta bored and website to research yourself instead of a platform for attacking others personally.

You lot are obsessed with Avacta. Youre always bringing it up just because I have my doubts about audioboom and convey them on the audioboom bulletin bored and instead of talking about audioboom your like yeah but avacta this avacta that and avacta the other lol

End of the day avacta are a totally different company and proposition. You or a loved one are highly likely to be taking there life saving drugs in the future so id not be so quick to dismiss them.

4 years of exquisite clinical data, proving there platform drug delivery system works and can target 90% of all solid tumours. Big pharma companies all exposed to enormous patent cliffs and are on the M&A offensive, deals going through for huge premiums and Avacta have said no to deals until this point now as we have enough clinical data to drive a higher price. Directors all have plenty of options, I don't care if they haven't got significant private holdings alongside this. Look what good that has done for audioboom.

Avacta is a 100x bagger from here, audioboom is a 3 or 4 bagger at most. The avacta risk reward is unparalleled. I can go on and on about how the investment is superior in every way but I prefer to talk about audioboom on the audioboom bulletin bored

Great response and thanks for that. Patent protection guarantee next week should give a decent boost of confidence.

With company still unprofitable, is there any danger of another raise anytime soon?